ALGEN.PA Current Ratio

As of 2025-07-15, the Current Ratio of Genoway SA (ALGEN.PA) is 1.99.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

ALGEN.PA Current Ratio - Historical Value

Date	Value
2024-12-31	1.99
2023-12-31	2.06
2022-12-31	2.21
2021-12-31	2.27
2020-12-31	1.8
2019-12-31	1.48
2018-12-31	1.45
2017-12-31	1.81
2016-12-31	1.67
2015-12-31	1.55

ALGEN.PA Current Ratio - Peers Comparison

Ticker	Name	Value
ABNX.PA	Abionyx Pharma SA	1.58
ABVX.PA	Abivax SA	1.82
ACTI.ST	Active Biotech AB publ	4.4
AEGIR.ST	Aegirbio AB	1.64
ALCLS.PA	Cellectis SA	1.73
ALLR.ST	Allarity Therapeutics A/S	0.4
ALNEV.PA	Neovacs SA	0.64
ALNOV.PA	Novacyt SA	6.33
ALNOX.PA	Noxxon Pharma NV	1.84
ALPAT.PA	Plant Advanced Technologies PAT SA	0.57
ALPRE.PA	Predilife SA	3.22
ATORX.ST	Alligator Bioscience AB	0.35
DBV.PA	Dbv Technologies SA	1.43
EVG.L	Evgen Pharma PLC	7.36
GEN.WA	Genomed SA	5.89
GUARD.ST	Guard Therapeutics International AB (publ)	3.14
GV.PA	Genomic Vision SA	0.91
IKM.MC	1nkemia IUCT Group SA	0.08
IPH.PA	Innate Pharma SA	2.6
IVA.PA	Inventiva SA	0.92
KURN.SW	Kuros Biosciences AG	2.14
LIDDS.ST	Lidds AB	3.3
LYS.PA	Lysogene SA	1.21
MTPH.L	Midatech Pharma PLC	6.39
MVIR B.ST	Medivir AB	4.39
NANO.PA	Nanobiotix SA	1.04
PROMO.ST	Promore Pharma AB	3.33
PUR.WA	Pure Biologics SA	0.14
RENE.L	ReNeuron Group PLC	2.05
SCS.WA	Stem Cells Spin SA	14.08
SENZA.ST	SenzaGen AB	2.66
SIGHT.PA	Gensight Biologics SA	0.24
SPRINT.ST	Sprint Bioscience AB	1.14
TNG.PA	Transgene SA	1.79
TRX.L	Tissue Regenix Group PLC	4.03
VAL.L	ValiRx PLC	5.5
VLA.PA	Valneva SE	2.61
XINT.ST	Xintela AB	0.78